Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
about
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasiaCelecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo.Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.Celecoxib induces apoptosis but up-regulates VEGF via endoplasmic reticulum stress in human colorectal cancer in vitro and in vivo.
P2860
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
@ast
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
@en
type
label
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
@ast
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
@en
prefLabel
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
@ast
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
@en
P2860
P1476
Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
@en
P2860
P356
10.1111/J.1443-9573.2006.00236.X
P577
2006-01-01T00:00:00Z